Immunome Inc (IMNM)
11.22
-0.05
(-0.44%)
USD |
NASDAQ |
Jan 06, 16:00
11.16
-0.06
(-0.53%)
After-Hours: 20:00
Immunome Profit Margin (Quarterly): -1.62K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -10.57K% |
| IGC Pharma Inc | -416.7% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Protalix BioTherapeutics Inc | 18.02% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -173.4% |
| Return on Assets | -137.0% |
| Return on Invested Capital | -173.4% |
| Operating Margin (Quarterly) | -1.51K% |
| Return on Net Operating Assets | -4.75K% |